vimarsana.com

Latest Breaking News On - Allergy asthma network - Page 7 : vimarsana.com

Benralizumab Receives FDA Approval as Add-On Maintenance Therapy for Asthma

The FDA approval of benralizumab for patients ages 6 to 11 with asthma follows the conclusions of the phase 3 TATE study.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.